Don C. Yoo

2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities

The Role of Imaging for GI Bleeding: ACG and SAR Consensus Recommendations

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

Diagnostic Performance and Safety of ¹⁸ F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)

A VISION Substudy of Reader Agreement on⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for¹⁷⁷Lu-PSMA-617 Radioligand Therapy

ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update

ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update

Gastrointestinal Bleeding at CT Angiography and CT Enterography: Imaging Atlas and Glossary of Terms

ACR Appropriateness Criteria® Adrenal Mass Evaluation: 2021 Update

ACR Appropriateness Criteria® Hematuria

U.S. PET/CT and Gamma Camera Diagnostic Reference Levels and Achievable Administered Activities for Noncardiac Nuclear Medicine Studies

ACR Appropriateness Criteria® Acute Onset of Scrotal Pain-Without Trauma, Without Antecedent Mass

ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer

ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer

ACR Appropriateness Criteria® Acute Pyelonephritis

ACR Appropriateness Criteria® Renovascular Hypertension

ACR Appropriateness Criteria ® Hematospermia